Clearside Biomedical, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Clearside Biomedical, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Clearside Biomedical, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $736K, a 26.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $736K -$260K -26.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $803K -$254K -24% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $869K -$248K -22.2% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $933K +$707K +313% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $996K +$720K +261% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.06M +$733K +226% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.12M +$748K +203% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $226K -$186K -45.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $276K -$176K -38.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $324K -$167K -34% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $369K -$159K -30.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $412K -$151K -26.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $452K -$143K -24% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $491K -$136K -21.7% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $528K -$128K -19.5% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $563K -$243K -30.1% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $595K -$272K -31.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $627K -$298K -32.2% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $656K Dec 31, 2019 10-K 2021-03-15
Q3 2019 $806K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $867K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $925K Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.